With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Serious Morbidity and Financial Outcomes Among Pediatric Cancer Survivors||Fred Hutchinson Cancer Research Center / Beth Mueller, PhD||Epidemiology Grants||2014||Washington|
|Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2006||Washington|
|Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants||University of Washington, Seattle / Abbye McEwen, MD, PhD||RUNX1 Early Career Investigator Grants||2022||Washington|
|Self-Management of Cancer-Related Fatigue by Adolescents: Pilot Study of an Evidence Based Educational Resource.||Seattle Children's Hospital and Regional Medical Center / Catherine Fiona Macpherson||Nurse Researcher Grants||2008||Washington|
|Targeting Novel Pediatric-Specific FLT3 Mutations||Fred Hutchinson Cancer Research Center / Soheil Meshinchi, MD,PhD||Reach Grants||2015||Washington|
|Niche for in Vitro Generation of Hematopoietic Stem Cells from Pluripotent Stem Cells||Fred Hutchinson Cancer Research Center / Brandon Hadland, MD, PhD||Young Investigator Grants||2014||Washington|
|TrkB Signaling in the Genesis of Murine Neuroblastoma||University of Vermont / Rae Nishi, PhD||Innovation Grants||2007||Vermont|
|Critical Contributions of CRM1 to Leukemogenesis||University of Vermont / Jessica Linda Heath, MD||Young Investigator Grants||2015||Vermont|
|LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma||University of Virginia, School of Medicine / Michael Engel, MD/PhD||Reach Grants||2016||Virginia|
|Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma||University of Virginia, School of Medicine / John Bushweller, PhD||Innovation Grants||2015||Virginia|